Abstract
Every day, cardiac surgeons, cardiac anesthesiologists and intensivists ponder the dilemma of whether or not to perform a blood transfusion on their patients. Transfusion practice in the United States varies widely, with several studies showing a 10-92% range for perioperative transfusion in cardiac surgical patients.1-4 These results may reflect a longstanding threshold of 10/30 (hemoglobin of 10g/dl and hematocrit of 30%) to initiate a transfusion in surgical patients.5-8 In fact, cardiac surgery cases account for approximately 10-20% of all blood transfusions, while a small sub-group of high-risk patients (10-20%) consume the other 80% of this scarce resource.9 In general, blood transfusion to treat moderate anemia is not looked upon as a major intervention with significant consequences, especially since immediate adverse side effects may not be apparent.
DOI: https://doi.org/10.14797/mdcvj.100 | Journal eISSN: 1947-6108
Language: English
Page range: 10 - 12
Published on: Jan 1, 2007
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2007 Faisal Masud, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.